Hims Stock Earnings Date: Complete Investor Guide

Knowing the hims stock earnings date is essential for investors tracking the telehealth sector and digital healthcare innovation. Hims & Hers Health, Inc. (NYSE: HIMS) has become a focal point for retail and institutional traders due to its aggressive growth in personalized medicine and high-frequency reporting cycles. This article provides a comprehensive overview of the HIMS earnings schedule, historical performance, and what to watch in upcoming financial releases.

1. Hims & Hers Health (HIMS) Earnings Overview

Hims & Hers Health is a multi-specialty telehealth platform listed on the New York Stock Exchange. As a public company, it is required to disclose its financial health quarterly. The hims stock earnings date typically marks a period of significant volatility and volume as the market reacts to user growth, revenue guidance, and the company's expansion into categories like weight loss (GLP-1) and hair care.

2. Upcoming Hims Stock Earnings Date

2.1 Next Scheduled Report

Based on current financial cycles, the next hims stock earnings date is estimated to be February 23, 2026, for the Fourth Quarter (Q4) 2025 results. According to reports from market analysts as of late 2024, the company traditionally releases its results after the market closes (AMC), followed by a live management presentation.

2.2 How to Access the Earnings Call

Investors can participate in the earnings process through the following channels:

• Webcast: Available via the Hims & Hers Investor Relations website.
• Conference Call: Dial-in numbers are usually provided in a press release one week prior to the hims stock earnings date.
• SEC Filings: Detailed 10-Q or 10-K reports are filed with the Securities and Exchange Commission immediately following the announcement.

3. Historical Earnings Performance

3.1 Q3 2025 Results Recap

On the hims stock earnings date of November 3, 2025, the company reported a robust quarter. Key highlights included:

• Revenue: $599 million, representing a nearly 50% year-over-year increase.
• EPS (Earnings Per Share): Reported at approximately $0.06 to $0.09 (GAAP vs. Adjusted), beating analyst consensus.
• Subscribers: Reached a milestone of 2.5 million core subscribers.

3.2 Earnings Surprise History

HIMS has established a trend of "beating" analyst expectations. Over the last four quarters, the company has consistently exceeded EPS estimates, often leading to immediate post-market price surges. However, investors should monitor the "post-earnings drift," where the stock price may consolidate after the initial reaction.

4. Key Financial Metrics to Watch

4.1 Revenue and Subscriber Growth

The primary driver for HIMS is its subscription-based model. During every hims stock earnings date, analysts focus on the "Monthly Online Revenue" and the retention rates of its 2.5 million subscribers. Growth in personalized treatments, particularly in the weight-loss and longevity segments, remains a critical metric.

4.2 Profitability and EBITDA

While early-stage telehealth companies often prioritize growth over profit, HIMS has transitioned toward consistent Net Income. As of late 2025, the company’s Adjusted EBITDA margins have shown steady improvement, aligning with its long-term strategic goal of sustainable profitability by 2030.

5. Market Sentiment and Price Targets

Following the most recent hims stock earnings date, Wall Street sentiment has remained largely positive. Analysts frequently update their price targets based on the company's revenue guidance. Current ratings generally lean toward "Buy" or "Hold," with price targets adjusted for the competitive landscape of the pharmacy and telehealth industry.

6. Business Outlook and Strategic Initiatives

Management forecasts often provide the most significant impact on the stock price during the earnings call. Investors look for updates on:

• Product Expansion: Progress in GLP-1 (weight loss) compounding and mental health services.
• Longevity Specialty: New ventures into preventative medicine and lab testing.
• Technology Integration: The use of AI to personalize patient treatments and improve margins.

7. Resources for HIMS Investors

To stay updated on the next hims stock earnings date, investors should utilize the following resources:

• The Hims & Hers Investor Relations Portal for official press releases.
• Financial news aggregators for real-time EPS alerts.
• Official Shareholder Letters which outline the company's long-term mission and strategic pivots.

While Hims & Hers Health operates in the traditional equity market, many modern investors use platforms like Bitget to diversify their portfolios into digital assets. Exploring the intersection of fintech and healthcare can provide a more balanced approach to modern wealth management.